Freemont Management S.A. Purchases 97,800 Shares of Astera Labs, Inc. $ALAB

Freemont Management S.A. lifted its position in Astera Labs, Inc. (NASDAQ:ALAB) by 693.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 111,900 shares of the company’s stock after acquiring an additional 97,800 shares during the period. Astera Labs accounts for 3.2% of Freemont Management S.A.’s holdings, making the stock its 6th largest position. Freemont Management S.A.’s holdings in Astera Labs were worth $18,616,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after buying an additional 84,365 shares in the last quarter. State Street Corp lifted its position in Astera Labs by 9.1% during the third quarter. State Street Corp now owns 2,339,451 shares of the company’s stock worth $458,065,000 after buying an additional 195,992 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Astera Labs by 46.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after buying an additional 479,360 shares in the last quarter. Amundi lifted its position in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Finally, Value Aligned Research Advisors LLC lifted its position in Astera Labs by 16.7% during the third quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock worth $269,881,000 after buying an additional 197,320 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Stock Up 9.6%

NASDAQ:ALAB opened at $224.09 on Thursday. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $262.90. The company has a market capitalization of $38.41 billion, a P/E ratio of 151.41, a P/E/G ratio of 3.37 and a beta of 3.35. The stock’s fifty day moving average is $150.64 and its two-hundred day moving average is $155.42.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the business earned $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently commented on ALAB. Barclays lifted their price objective on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. TD Cowen lifted their price objective on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. JPMorgan Chase & Co. lifted their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Rothschild & Co Redburn began coverage on Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Finally, Susquehanna lifted their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Fifteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $229.65.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 230,639 shares of Astera Labs stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $198.22, for a total value of $45,717,262.58. Following the sale, the chief operating officer owned 664,361 shares in the company, valued at $131,689,637.42. The trade was a 25.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of Astera Labs stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total value of $28,012,592.16. Following the completion of the sale, the chief executive officer owned 3,929,183 shares in the company, valued at $786,465,269.28. This represents a 3.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,497,338 shares of company stock worth $236,827,957 over the last quarter. 12.50% of the stock is currently owned by company insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.